January 2, 2009

MEDTRONIC INC: Has $95M in Disputed CRT Royalties as of Oct. 24

COMPANIES: Medtronic Inc
Subscribe

The amount of disputed royalties and interest related to certain of Medtronic, Inc.’s cardiac resynchronization therapy products has reached US$95 million, as of Oct. 24, 2008.

Medtronic is a licensee to…

TO CONTINUE READING,LOGIN or
TOPICS: Biotechnology | Drugs/Pharmaceuticals | Legal Issues, Litigation | Medical Supplies | Medical Technology | Patents, Intellectual Prop. | SEC-Qtrly, Annual Reports | Securities & Exch Comm, US
LOCATIONS: Minnesota | United States